NCT04441177

Brief Summary

Compared to conventional rehabilitation therapy, the full-immersive commercial game (CG) system, in the form of available video game, could safely provide more positive effect on health-related quality of life (HRQOL) and motor function in post-stroke patients. The study aims to perform the research from 2019/7/1 to 2021/6/30 and enrolls a total of 80 participants. Stroke participants are recruited from the rehabilitation ward of CGMH hospital. The inclusion criteria are (a) first-time unilateral cerebral stroke, (b) stroke onset less or equal to 1 year, (c) admission to the rehabilitation ward, (d) ages 20-80 years, (e) spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale, and (f) no active medical problems such as fever, pneumonia, or scabies. The exclusion criteria are (a) brainstem or cerebellar stroke, (b) epilepsy history, including photosensitive epilepsy, (c) previous or active heart diseases, such as myocardial infarction or angina, (d) visuospatial problems related to stroke, such as hemianopia or hemineglect, (e) paretic upper limb reaches Brunnstrom recovery stage VI, (f) severe aphasia, (g) severe cognitive impairment, and (h) poor cooperation with assessments. All participants are randomly allocated to study group and control group. Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays. Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period. Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale 3.0. Motricity Index and Fugl-Meyer Assessment, Functional Independence Measure, and arm movement ratio will also be checked before intervention, after intervention, and at 3-month follow-up. The safety outcome, intervention-related adverse events or any serious adverse events, during study period will be recorded.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 29, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 22, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

1.9 years

First QC Date

June 16, 2020

Last Update Submit

June 19, 2020

Conditions

Keywords

StrokeVirtual RealityRehabilitation

Outcome Measures

Primary Outcomes (4)

  • Stroke Impact Scale (SIS) 3.0 Questionnaire

    Health-Related Quality of Life

    Baseline (Pre-intervention at 2 days after enrollment)

  • Post-Intervention Change of Stroke Impact Scale (SIS) 3.0 Questionnaire

    Post-intervention Health-Related Quality of Life

    Change from baseline SIS scores at 18 days after enrollment

  • 3-Month Follow-Up Change of Stroke Impact Scale (SIS) 3.0 Questionnaire

    3-month follow-up Health-Related Quality of Life

    Change from baseline SIS scores at 92 days after enrollment

  • Post-Intervention of Adverse Events or SAE

    Proportion of intervention-related adverse events or SAE

    16 days

Secondary Outcomes (12)

  • Motricity Index (MI) Upper Extremity Test

    Baseline (Pre-intervention) at 2 days after enrollment

  • Post-Intervention Change of Motricity Index (MI) Upper Extremity Test

    Change from baseline MI scores at 18 days after enrollment

  • 3-Month Follow-Up Change of Motricity Index (MI) Upper Extremity Test

    Change from baseline MI scores at 92 days after enrollment

  • Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    Baseline (Pre-intervention) at 2 days after enrollment

  • Post-Intervention Change of Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    Change from baseline FMA-UE scores at 18 days after enrollment

  • +7 more secondary outcomes

Study Arms (2)

Study group

EXPERIMENTAL

Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.

Device: PlayStation®VR training

Control group

NO INTERVENTION

Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays.

Interventions

Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.

Study group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first-time unilateral cerebral stroke
  • stroke onset less or equal to 1 year
  • admission to the rehabilitation ward
  • ages 20-80 years
  • spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale
  • no active medical problems such as fever, pneumonia, or scabies

You may not qualify if:

  • brainstem or cerebellar stroke
  • epilepsy history, including photosensitive epilepsy
  • previous or active heart diseases, such as myocardial infarction or angina
  • visuospatial problems related to stroke, such as hemianopia or hemineglect
  • paretic upper limb reaches Brunnstrom recovery stage VI
  • severe aphasia
  • severe cognitive impairment
  • poor cooperation with assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chiayi Chang Gung Memorial Hospital

Pozi, 613, Taiwan

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Chien-Min Chen, MD

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale (SIS) 3.0. Motricity Index (MI) and Fugl-Meyer Assessment (FMA), Functional Independence Measure (FIM), and arm movement ratio (AMR) will also be checked before intervention, after intervention, and at 3-month follow-up. One blinded occupational therapist will evaluate the outcomes.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All participants are randomly allocated to study group and control group. Each participant's main study period is set as 16 days with additional follow-up time at post-intervention 3 months. Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays. Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 16, 2020

First Posted

June 22, 2020

Study Start

July 29, 2019

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

June 22, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations